September 22, 2024

Join the FOCI forum and get the relationships and information you need in the best available FOCI executive group

Home
About Us
GovCon Finance
Market Reports
Advertise

Hello, Guest!

Pfizer, Lilly Reveal Phase 3 Results for Tanezumab

Home Uncategorized Pfizer, Lilly Reveal Phase 3 Results for Tanezumab

February 20, 2019September 15, 2024By

Previous PostMedtronic Develops ‘PRODIGY Score’ for OIRD Risk PredictionNext PostArmy Posts RFI for Virtual Health Technology

EVENTS

NOMINATIONS ARE NOW OPEN FOR 2024 WASH100 AWARD

GOVCON VIDEOS

TOP SEARCHES

Accenture Accenture plc AeroVironment BAE Systems Boeing Boeing Company Booz Allen Hamilton CACI CAE Carlyle Group CGI CGI Group Cisco Systems Curtiss-Wright Fluor Corporation General Dynamics Globalstar Globalstar Inc. GovCon GovCon. GovCon Index GovCon Index GovConIndex HII Honeywell Honeywell International ICF Jacobs Jerome Powell KBR Kratos Kratos Defense & Security Solutions L3Harris Technologies Leidos Lockheed Martin Maximus Mercury Systems Northrop Grumman Palantir Technologies Parsons Parsons Corporation RTX Science Applications International Corporation Tetra Tech Textron V2X

Executive Mosaic
8245 Boone Boulevard Suite 650
Tysons Corner, VA 22182

[email protected]

CATEGORIES

Contract Awards

Financial Reports

INFORMATION AND UPDATES

REPORTS

GovCon Index Report

GovCon Index Weekly Report

GovCon Index Monthly Report

© 2023 GovconIndex - All Rights Reserved

Get unlimited access today. Continue reading with one of the options below

Login Here

To enjoy unlimited access to articles, interviews, and invaluable govcon content. You’ll also receive our daily briefing straight to your inbox.

By submitting my information, I agree to the Privacy Policy and Terms of Service.